Children With Asthma More Likely To Struggle in School, Study Says
Researchers investigated whether children with poorly controlled asthma are more likely to struggle academically.
Latest News
LATEST NEWS
How Preventable Is Sepsis-Associated Death in Hospitalized Adults?
While sepsis was the most common immediate cause of death at 6 US academic and community hospitals, most patients had severe chronic comorbidities.
Chronic Rhinosinusitis Associated With Risk for Depression and Anxiety
Patients with chronic rhinosinusitis were at higher risk for developing depression and anxiety.
Gender, Age, and Etiology Do Not Affect Response to PAH Treatment
Age, gender, and etiology significantly influence prognosis together with the recently validated simplified PAH risk table but don’t significantly influence the response to PAH-specific treatment.
AMA Code of Medical Ethics: Guidelines for Immigrant Patient Care
The AMA Code of Medical Ethics offers guidance on how physicians and healthcare systems can best support undocumented and lawfully present immigrants to promote the best possible care for all who need it.
Limiting the Documentation of Patient Immigration Status in Medical Records
This commentary examines physician options for documenting immigration status considering ethical, legal, and historical circumstances when caring for stigmatized populations during changing political landscapes.
COPD Exacerbation Hospitalization Risk Factors Differ by Sex
Risk factors for 30-day hospital readmission after a COPD exacerbation differed by sex.
Future WTC Lung Injury Predicted by Metabolic Syndrome
Metabolic syndrome biomarkers have been validated as predictors of World Trade Center-related lung injury.
FDA to Review BLA for Oral Immunotherapy AR101 for Peanut Allergy
The Food and Drug Administration has accepted for review the Biologics License Application for AR101 (Aimmune Therapeutics) to reduce the risk of anaphylaxis following accidental exposure to peanut.
Atezolizumab Plus Chemotherapy Approved for Initial Treatment of Extensive-Stage Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab; Genentech), in combination with carboplatin and etoposide, for the first-line treatment of adult patients with extensive-stage small cell lung cancer.
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
An analysis found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions.
Cyclophosphamide Offers Short-Term Improvements in SSc-Interstitial Lung Disease
In patients with symptomatic systemic sclerosis (SSc)-related interstitial lung disease (ILD), 1-year treatment with the immunosuppressant cyclophosphamide (CYC) is associated with short-term improvements in forced vital capacity (FVC)%-predicted and the modified Rodnan skin score (mRSS), but not in the diffusing capacity of the lungs for carbon monoxide (DLCO)%-predicted. A comparison of the Scleroderma Lung Study…
Digital Subtraction Pulmonary Angiography in Children With PH Due to BPD
Digital subtraction pulmonary angiography is a potentially useful imaging modality for evaluating changes in the pulmonary vasculature of children with pulmonary hypertension associated with bronchopulmonary dysplasia.
Sleep Apnea Severity Linked to Elevated Pulmonary Capillary Wedge Pressure
Sleep apnea severity was associated with elevated pulmonary capillary wedge pressure in adults.
Balloon Pulmonary Angioplasty Safely Treats CTEPH in Older Patients
Balloon pulmonary angioplasty was considered safe and effective even in patients considered “oldest-old” with chronic thromboembolic pulmonary hypertension.
Want to read more?
Please login or register first to view this content.